ASLAN004

· ASLAN Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASLAN004, covering 2024-04-26 to 2024-04-26. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis [Phase 2]